GlaxoSmithKline Financial Statements
GlaxoSmithKline Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
GlaxoSmithKline Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 45,345.7 | 45,479.2 | 37,272.5 |
| Gross Profit ($ mil.) | -- | -- | 29,074.6 |
| Operating Income ($ mil.) | -- | -- | 9,070.3 |
| Total Net Income ($ mil.) | -- | -- | 5,740.6 |
| Diluted EPS (Net Income) | -- | -- | 2.12 |
GlaxoSmithKline Stock Quote & Chart
10/07/08 15:03:52 EST •
NYSE •
41.16
•
 -0.2600
•
-0.6277 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
GlaxoSmithKline Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.41 | 3.31 | 1.48 |
| Price/Earnings Ratio | 23.26 | 14.57 | 15.28 |
| Price/Book Ratio | 0.98 | 2.76 | 1.45 |
| Price/Cash Flow Ratio | 1.53 | 12.29 | 9.29 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed GlaxoSmithKline Financial Ratios
GlaxoSmithKline Competitive Intelligence
| Novartis | Pfizer | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 38,947.0 | 48,418.0 | 43,019.0 |
| Employees | 98,200 | 86,600 | 99,495 |
| Market Cap ($ mil.) | -- | 122,955.7 | -- |
Competitive Landscape
